EcoDrugPlus

Ensembl ID : ENSATEG00000005226
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSATEG00000015702
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSATEG00000002576
Gene Symbol: -
Cross references: -
390 Possible Orthologues:

Ensembl ID : ENSATEG00000006853
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSATEG00000014920
Gene Symbol: -
Cross references: -
307 Possible Orthologues:

Ensembl ID : ENSATEG00000014900
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSATEG00000014858
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSATEG00000025089
Gene Symbol: -
Cross references: -
234 Possible Orthologues:

Ensembl ID : ENSATEG00000011252
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSATEG00000030059
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSATEG00000029934
Gene Symbol: -
Cross references: -
241 Possible Orthologues:

Ensembl ID : ENSATEG00000014848
Gene Symbol: -
Cross references: -
385 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).